The European Medicines Agency (EMA) announced on Thursday August 18 that it is examining a new vaccine against Covid-19 developed by the German laboratory SK Chemicals which relies on nanotechnology to attack the virus, in anticipation of a possible resurgence of the pandemic in the fall.
If approved, the vaccine, called Skycovion, will be the seventh approved in the European Union, while other new vaccines are also being reviewed by the European Agency based in Amsterdam for approval in the EU. EU.
SK Chemicals “
submitted data on the ability of this new vaccine to trigger the production of antibodies against the initial strain of SARS-CoV-2, the virus responsible for Covid-19
”, explained the EMA.
Read alsoNew Covid vaccines will be more effective against Omicron
The vaccine relies on nanoparticles containing elements of the Spike protein which is the key to allowing SARS-CoV-2 to enter human cells.
The vaccine developed by SK Chemicals also contains an "
adjuvant
" to boost the body's immune response to the vaccine, the agency said.
To date, the European Union has authorized the use of vaccines developed by AstraZeneca, Janssen, BioNTech-Pfizer, Moderna, Novavax and Valneva, which has suspended its production of vaccines against Covid.
